Gene polymorphisms identified that are responsible for breast density and cancer risk

October 24, 2012

It has long been known that breast density, or mammographic density, is a strong risk factor for breast cancer, and that estrogen and progestin hormone therapy increases dense breast tissue. Now, a study published in BioMed Central's open access journal Breast Cancer Research has identified several gene variants in hormone metabolism and growth factor pathways that may be associated with breast density and, hence, breast cancer risk.

Mammographic density relates to the fact that x-rays permeate different types of breast tissue in different ways, leading to white areas on the mammogram. Fatty tissue appears on the mammogram as relatively translucent, whereas dense breast tissue contains more stromal tissue and , appearing as white areas. Women with a breast density of 75% or more have a 4-5 times higher risk of developing than women of the same age with little or no density.

Controversy exists over why breast density is a cancer risk. Many studies suggest that density is at least partially inherited, and twin studies show that genetic factors do play a role in the variation observed. Breast density decreases naturally with older age and menopause, but also increases with hormone therapy. Merete Ellingjord-Dale and co-authors, from academic centers in Norway and Los Angeles, set out to investigate which genes could play a role in determining breast density. Because of the clear involvement of hormones, they were looking particularly for genes involved in hormone metabolism.

Using data from 2,036 women who participated in the Norwegian Program in 2004, and separating the participants into hormone therapy users and non-users, the authors found that different gene variants appeared to be important depending on the women's hormone therapy usage.

There was evidence to suggest that variants in the prolactin (PRL) gene were associated with breast density in users of estrogen and progestin, as well as norethisterone acetate (a common regimen in Nordic countries). In non-users of hormone therapy, variants in the tumor necrosis factor (TNF) and SULT1A1/2 genes were significantly associated with breast density.

The findings suggest that several genes in hormone metabolism and growth factor pathways are indeed implicated in determining , and might increase . Commenting on the findings, lead author, Merete Ellingjord-Dale said, "One reason it has been so difficult to pinpoint which genes are responsible for mammographic density is that the effect of some genetic variants may be amplified in combination with hormone therapy. Consequently in the presence of hormone therapy these genes cause increased density."

She continued, "It is important to consider both the genetic and non-genetic factors simultaneously. Exploring the functional role of gene variants associated with mammographic density could further clarify the biological mechanisms involved. "

Explore further: Breast tenderness in women getting combo hormone therapy associated with increase in breast density

Related Stories

Breast tenderness in women getting combo hormone therapy associated with increase in breast density

October 14, 2011
Post-menopausal women who experience new onset breast tenderness after starting combination hormone therapy may have an increased risk of breast cancer compared to women who don't experience breast tenderness, a study by ...

Breast tenderness linked to increased breast density

October 24, 2011
(Medical Xpress) -- Post-menopausal women who experience breast tenderness after starting combination hormone therapy have a higher risk of breast cancer than women who don't, a study by researchers with UCLA's Jonsson Comprehensive ...

Breast density does not influence breast cancer death among breast cancer patients

August 20, 2012
The risk of dying from breast cancer was not related to high mammographic breast density in breast cancer patients, according to a study published August 20 in the Journal of the National Cancer Institute.

Breast density tied to specific types of breast cancer

July 27, 2011
Women with breasts that appear dense on mammograms are at a higher risk of breast cancer and their tumors are more likely to have certain aggressive characteristics than women with less dense breasts, according to a study ...

Breast cancer patients with high density mammograms do not have increased risk of death

September 7, 2012
(Medical Xpress)—High mammographic breast density, which is a marker of increased risk of developing breast cancer, does not seem to increase the risk of death among breast cancer patients, according to a study led by Gretchen ...

Recommended for you

Compound shows promise in treating melanoma

July 26, 2017
While past attempts to treat melanoma failed to meet expectations, an international team of researchers are hopeful that a compound they tested on both mice and on human cells in a petri dish takes a positive step toward ...

Study uncovers potential 'silver bullet' for preventing and treating colon cancer

July 26, 2017
In preclinical experiments, researchers at VCU Massey Cancer Center have uncovered a new way in which colon cancer develops, as well as a potential "silver bullet" for preventing and treating it. The findings may extend to ...

Understanding cell segregation mechanisms that help prevent cancer spread

July 26, 2017
Scientists have uncovered how cells are kept in the right place as the body develops, which may shed light on what causes invasive cancer cells to migrate.

Study may explain failure of retinoic acid trials against breast cancer

July 25, 2017
Estrogen-positive breast cancers are often treated with anti-estrogen therapies. But about half of these cancers contain a subpopulation of cells marked by the protein cytokeratin 5 (CK5), which resists treatment—and breast ...

Physical activity could combat fatigue, cognitive decline in cancer survivors

July 25, 2017
A new study indicates that cancer patients and survivors have a ready weapon against fatigue and "chemo brain": a brisk walk.

Breaking the genetic resistance of lung cancer and melanoma

July 25, 2017
Researchers from Monash University and the Memorial Sloan Kettering Cancer Center (MSKCC, New York) have discovered why some cancers – particularly lung cancer and melanoma – are able to quickly develop deadly resistance ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.